These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 6635970)
61. Formation of uroporphyrinogen IV during the chemical dimerization of 2-aminomethyl-3',3'-carboxymethyl-4,4' (beta-carboxyethyl) dipyrrylmethane. Frydman RB; Frydman B FEBS Lett; 1975 Apr; 52(2):317-22. PubMed ID: 1132489 [No Abstract] [Full Text] [Related]
62. Assay of free erythrocyte porphyrins in man. Some notes on Rimington's (1963) procedure. Van der Merwe L; Findlay GH S Afr J Med Sci; 1965 Oct; 30(3):49-56. PubMed ID: 5858742 [No Abstract] [Full Text] [Related]
63. [Azotemic anemia in isothenuric state in chronic glomerulonephritis]. GOBBATO F; DAL SANTO G Riforma Med; 1952 Aug; 66(31):841-5. PubMed ID: 13004703 [No Abstract] [Full Text] [Related]
64. [The behavior of blood lipids and cholesterol in chronic glomerulonephritis]. GUARINI G; MACALUSO M; GALIPO F Boll Soc Ital Biol Sper; 1962 Feb; 38():152-4. PubMed ID: 13902543 [No Abstract] [Full Text] [Related]
65. An open letter for help. Neumann ME Nephrol News Issues; 1990 Jun; 4(6):5, 43. PubMed ID: 2402312 [No Abstract] [Full Text] [Related]
66. Therapy of acute and chronic glomerulonephritis. DANOWSKI TS; MATEER FM J Chronic Dis; 1957 Jan; 5(1):122-37. PubMed ID: 13376706 [No Abstract] [Full Text] [Related]
67. [Advances in the treatment of acute and chronic glomerulonephritis. I]. SCHWALB H Med Klin; 1956 Aug; 51(33):1378-80. PubMed ID: 13358528 [No Abstract] [Full Text] [Related]
68. [Progress in the treatment of acute and chronic glomerulonephritis. II]. SCHWALB H Med Klin; 1956 Aug; 51(35):1480-3. PubMed ID: 13358557 [No Abstract] [Full Text] [Related]
69. Spontaneous recovery from rapidly progressive glomerulonephritis. Evans DJ Br Med J; 1979 Oct; 2(6195):936. PubMed ID: 519247 [No Abstract] [Full Text] [Related]
70. Red cell charge in glomerular disease. Boulton-Jones JM; McWilliams G; Chandrachud L Lancet; 1986 Oct; 2(8510):814. PubMed ID: 2876269 [No Abstract] [Full Text] [Related]
71. [Treatment of primary glomerulonephritis]. Nagy J Orv Hetil; 2005 Jan; 146(4):169-73. PubMed ID: 15751512 [No Abstract] [Full Text] [Related]
72. [Hemodialysis and metabolism of erythrocyte porphyrins in patients with chronic glomerulonephritis]. Chernova EI; Riabov SI; Chizhikova VA Ter Arkh; 1983; 55(9):131-4. PubMed ID: 6635970 [No Abstract] [Full Text] [Related]
73. [The mononuclear cell magnesium content in patients with chronic glomerulonephritis and on regular hemodialysis treatment]. Mori T Nihon Jinzo Gakkai Shi; 1985 Aug; 27(8):1185-91. PubMed ID: 4087538 [No Abstract] [Full Text] [Related]
74. Hemodialysis effect on the biosynthesis of porphyrins. Pisanetz M; Velichkova E; Ovanesian M Folia Med (Plovdiv); 1981; 23(3-4):56-60. PubMed ID: 6804338 [No Abstract] [Full Text] [Related]
75. [Morphology of diffuse glomerulonephritis during chronic intermittent hemodialysis]. Jenó O; Anikó M; Zsuzsanna K; György G Orv Hetil; 1974 Dec; 115(50):2972-5. PubMed ID: 4453413 [No Abstract] [Full Text] [Related]
76. [The blood pro- and antioxidant status in patients with chronic glomerulonephritis and disordered kidney function undergoing treatment with peroral sorbents]. Tugusheva FA; Kulikova AI; Lukichev BG; Zubina IM Urol Nefrol (Mosk); 1994; (6):39-42. PubMed ID: 7892720 [TBL] [Abstract][Full Text] [Related]